Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article published by OncLive referenced a Peer Exchange series by The American Journal of Managed Care® (AJMC®), titled “Advancing Precision Medicine Through Comprehensive Genomic Profiling (CGP).” The series provides payer and clinician insight regarding the integration of CGP into routine clinical practice to help oncologists make more informed treatment decisions for patients with cancer.
Several conference coverage articles and a video posted on AJMC.com, the website of AJMC®, were featured in the Comparative Effectiveness Research Daily Newsfeed distributed by the National Pharmaceutical Council. The content referenced include:
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More